In January, Avista Capital Partners, a leading private equity firm, bought Bristol-Myers Squibb's Medical Imaging business unit for approximately $525 million. Now Avista has announced that the unit, a leading supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures, is named Lantheus Medical Imaging. A new executive team has also been appointed.

Bristol-Myers Squibb Medical Imaging was widely recognized as a pioneer in pharmaceutical products and medical imaging agents, and for strong technical manufacturing expertise. The business also enjoys exceptional brands, a cutting-edge research and development facility, promising pipeline, and a knowledgeable sales force to boost Avista's portfolio, the company said.

Read prior DOTmed News reporting on this topic at:

www.dotmed.com/news/story/5197

More Voices